The goal of this study is to evaluate the effectiveness of a standardized lymphedema and fibrosis self-management program (LEF-SMP) to improve LEF self-management and reduce LEF-associated symptom burden, functional deficits, and improve quality of life in head and neck cancer (HNC) survivors.
>18 years of age
Post HNC primary treatment
No evidence of cancer (NED)
Completion of initial lymphedema therapy for head and neck lymphedema
Recurrent or metastatic cancer
Any other active cancer
Acute infection
Acute congestive heart failure
Abramson Cancer Center at Penn Medicine
Lead sponsor
United States Department of Defense
Collaborator